Patrick Hsu — SPARQNOW

At-a-Glance

Co-founder and Core Investigator of Arc Institute, a nonprofit research organization focused on accelerating biomedical discovery.
Assistant Professor of Bioengineering and Deb Faculty Fellow at the University of California, Berkeley.
Co-invented CRISPR-Cas9 for human genome editing and discovered the first programmable recombinases.
Founded multiple biotech companies, including Terrain Biosciences, Stylus Medicine, and Monet AI.
Recognized in MIT Technology Review’s Innovators Under 35 (2017) and Forbes 30 Under 30 in Science (2015).
Earned his Ph.D. from Harvard University and his bachelor's degree from UC Berkeley.

Biography

Patrick Hsu is an American bioengineer, entrepreneur, and investor, recognized for his contributions to CRISPR gene editing, machine learning, synthetic biology, and gene therapy. He is a co-founder and Core Investigator of the Arc Institute, a nonprofit research organization dedicated to accelerating biomedical discovery. Additionally, he serves as an Assistant Professor of Bioengineering and Deb Faculty Fellow at the University of California, Berkeley.